Once the efficacy study is done — the trial that proves definitively that progesterone works as a treatment for moderate to severe TBI — and after it is FDA-approved, progesterone would be a cheap and readily available drug.
Turn Text Only Off
Page Utilities
Click on any phrase to play the video at that point.
This is a phase III efficacy trial meaning that this is THE trial to prove whether
progesterone works for traumatic brain injury.
And if it's positive, we believe that it should be able to be used as soon as
the FDA gives approval--which should be relatively shortly after the trial.
I will say there's--progesterone--the technology of progesterone for traumatic brain injury
has actually been licensed by a company called BHR Pharma.
That actually is a good thing because BHR Pharma is running a separate trial--
separate from ours--and their trial is more international.
There are some subtle differences,
They're just in severe traumatic brain injury.
We're looking at moderate and severe, and our timing is different.
But most importantly is that their formulation is a little bit different.
They have developed a ready-to-use, stable formulation that would be ready to go to market
as soon as the FDA says, yep, let's go.
Ours is because we're academia--we're NIH-funded--
we weren't so concerned about trying to have something packaged and ready.
We're just basically trying to decide--does the drug work? Does progesterone work or not?
It would be a little bit more complicated to take what we use in the trial
because we compound it right before we ship it out to the different sites.
It would be a little more complicated,
so it's good that there's a partner out there already thinking along these lines--
to get a drug ready to be available.
It's very cheap. It's widely available. It comes from yams.
The drug company--BHR Pharma--
actually has promised that they're going to keep the drug inexpensive.
By the way, BHR Pharma already produces about 60% of the progesterone
sold in the world today, so their parent company--called Besins Pharmaceuticals--
is the company that has been working in this space for many years
in hormones and other things.
They're a Belgium-based company, and they have immense experience
and would be very-quickly able to ramp up and produce this at the level that would be needed.
Produced by Victoria Tilney McDonough, Ashley Gilleland, Justin Rhodes, and Erica Queen, BrainLine.
David Wright, MD, FACEP is a tenured associate professor in the Department of Emergency Medicine at Emory University, and the director of the division of Emergency Neurosciences. The Emergency Neurosciences program is dedicated to finding novel therapies for the treatment of rapidly evolving neurological conditions, including traumatic brain injury, stroke, status epilepticus, spinal cord injury and others.
The contents of Brainline (the “Web Site”), such as text, graphics, images, information obtained from the Web Site’s licensors and/or consultants, and other material contained on the Web Site (collectively, the “Content”) are for informational purposes only. The Content is not intended to be a substitute for medical, legal, or other professional advice, diagnosis, or treatment.
Specifically, with regards to medical issues, always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Web Site. If you think you may have a medical emergency, call your doctor or 911 immediately. The Web Site does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Web Site. Reliance on any information provided by the Web Site or by employees, volunteers or contractors or others associated with the Web Site and/or other visitors to the Web Site is solely at your own risk.
Related Content
Audio/Video:
In the next 5-10 years, we could see revolutionary changes to the way brain injury is treated, diagnosed, managed, and understood as an overall disease process.See more videos with Dr. Wright.
- Gaps and Challenges in TBI Research and What Next 5-10 Years Could Bring
- It's disheartening for physicians like Dr. David Wright to have to tell families with a loved one with severe TBI that, to date, there is no definitive treatment besides waiting and offering support.
See more videos with Dr. Wright.
- Raised Awareness of TBI Has Helped Boost Research Efforts
- Dr. David Wright talks about a heads-up display unit that, with active white noise reduction, takes the neurotesting room to the sidelines or to combat.
See more videos with Dr. Wright.
- Bringing an Immersive Neuropsych Tool to the Sidelines and to Theater
- When the brain is injured, the body's reparative system calls in the "clean-up cells." Unfortunately, they clean indiscriminately, which can cause more damage.
See more videos with Dr. Wright.
- Progesterone Helps Stop "Indiscrimate Cleaning" of Cells After Brain Injury
- The most damage from a TBI does not come from the injury itself but from the secondary consequences. Learn how progesterone can help because of its pleotrphic nature.
See more videos with Dr. Wright.
- The Pleiotropic Nature of Progesterone When Used to Treat TBI
- Dr. David Wright talks about the PROTECT III trial studying the use of progesterone for moderate to severe TBI and how you get patients' consent.
See more videos with Dr. Wright.
- How Do You Get a Patient's Consent to Be in a Trial If He is Unconscious?
- In the Phase III trial, humans are given natural progesterone — which comes from yams — within a four-hour window when it can coat the brain and offer neuro protection.
See more videos with Dr. Wright.
- How and When Progesterone Is Administered After a Brain Injury
- The story of one young man gives researchers like Dr. David Wright great hope that progesterone can be an effective treatment to help people recover from moderate to severe TBI.
See more videos with Dr. Wright.
- Progesterone Case Study: Remarkable Recovery
- Dr. David Wright explains how Dr. Donald Stein first started studying progesterone as a way to prevent swelling in the brain after a brain injury.
See more videos with Dr. Wright.
- The Back Story of the Brain Injury Progesterone Study
- Emory University scientist Michelle LaPlaca, PhD, talks about her work on DETECT, a low-cost, portable device to detect possible neurocognitive symptoms after a hit to the head.
- A Portable Device to Detect TBI on the Sidelines
BrainLine Footer
Getting Started |
Site Features |
Follow Us |
About |
Facebook
Twitter
LinkedIn
YouTube
RSS Feeds
BrainLine.org is a WETA website funded by the Defense and Veterans Brain Injury Center through a contract with the Henry M. Jackson Foundation. Government funding support is not an endorsement of WETA or any of its products, including this website.
© 2013 WETA All Rights Reserved
